In RA-ILD, genetic determinants of RA itself—particularly HLA-DRB1 shared epitope alleles and PADI4 polymorphisms—may contribute to ILD susceptibility through heightened systemic inflammation and autoantibody production [10,55]. The gene discussed is HLA-DRB1; the disease is interstitial lung disease.